Ostatnia aktualizacja :
19/11/2024
Lek przeciwnadciśnieniowy   Captopril  
Roztwór doustny
Torebka papierowa
Stabilność preparatów farmaceutycznych Trwałość w mieszaninie Czynnik wpływający na trwałość Zgodność Bibliografia pdf
   Struktura chemiczna  

Roztwór doustny
Bibliografia   Roztwór doustny   Bibliografia : Captopril  
typ publikacja
1736 Czasopismo Liu J, Chan Y, Ho PC.
Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
J Clin Pharm Ther 1999 ; 24: 145-150.
2432 Czasopismo Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC.
Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids
Am J Health-Syst Pharm 1997 ; 54: 2483-2487.
2433 Czasopismo Allen LV, Jr, Erickson MA,
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1996 ; 53: 2179-2184.
2463 Czasopismo Anaizi NH, Swenson C.
Instability of aqueous captopril solutions
Am J Hosp Pharm 1979 ; 50: 486-488.
2522 Czasopismo Nahata MC, Morosco RS, Hipple TF.
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate
Am J Hosp Pharm 1994 ; 51: 1707-1708.
2570 Czasopismo Chan DS, Sato AK, Claybaugh JR.
Degradation of captopril in solutions compounded from tablets and standard powder.
Am J Hosp Pharm 1994 ; 51: 1205-1207.
2642 Czasopismo Timmins P, Jackson IM, Yu-chang John Wang.
Factors affecting captopril stability in aqueous solution
Int J Pharm 1982 ; 11, 4: 329-336.
2827 Czasopismo Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S.
Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles
Am J Health-Syst Pharm 2009 ; 66: 1722-1725.
2906 Czasopismo Escribano Garcia MJ, Torrado Duran S, Torrado Duran JJ.
Stability study of an aqueous formulation of captopril at 1 mg/ml.
Farm Hosp 2005 ; 29: 30-36.
2984 Czasopismo Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A.
The development of a stable oral solution of captopril for paediatric patients.
EJHP Science 2007 ; 13-67-72.
3436 Czasopismo Geiger C. M, Sorenson B, Whaley P. A.
Stability of Captopril in SyrSPend SF.
Int J Pharm Compound 2013 ; 17, 4: 336-338.
3802 Czasopismo Sam W.J, Ho P.C.
Stability of captopril in invert sugar solution
J Clin Pharm Ther 1998 ; 23: 451-456.
4097 Czasopismo Casas M, Alvarez J, Lucero M.
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Pharm Dev Technol 2013
4689 Czasopismo Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M.
Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo.
Braz J Pharm Sci 2022 ;58: e19175

  Mentions Légales